HopeStage
Back to all studies
RecruitingNCT05580614

Vagus nerve stimulation paired with exposure therapy for OCD

About this titleRead the official source — NCT05580614
Device studyAges 18–55United States
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 55 years.

Listed locations
GainesvilleSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: June 27, 2022
Recruitment status
Recruiting
Enrollment listed in the registry
56
Sponsor
University of Florida
Sponsor type
University
Study type
Device
Intervention type
DEVICE
Study phase
Not clearly listed
Locations
United States
Age range
From 18 Years to 55 Years
Official registry ID
NCT05580614
Official title
Show the full official title

Pairing tVNS and Exposure and Response Prevention to Improve Symptoms of OCD

Recruitment & locations

Currently recruiting

Gainesville

FAQ

Questions about this study

Who is behind this study?

The study sponsor is University of Florida, a university.

Who can participate?

Listed age limits: 18 years to 55 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies